149 related articles for article (PubMed ID: 20157708)
1. Evaluation of the kappa-opioid receptor-selective tracer [(11)C]GR103545 in awake rhesus macaques.
Schoultz BW; Hjornevik T; Willoch F; Marton J; Noda A; Murakami Y; Miyoshi S; Nishimura S; Arstad E; Drzezga A; Matsunari I; Henriksen G
Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1174-80. PubMed ID: 20157708
[TBL] [Abstract][Full Text] [Related]
2. Determination of in vivo Bmax and Kd for 11C-GR103545, an agonist PET tracer for κ-opioid receptors: a study in nonhuman primates.
Tomasi G; Nabulsi N; Zheng MQ; Weinzimmer D; Ropchan J; Blumberg L; Brown-Proctor C; Ding YS; Carson RE; Huang Y
J Nucl Med; 2013 Apr; 54(4):600-8. PubMed ID: 23424192
[TBL] [Abstract][Full Text] [Related]
3. Kinetic Modeling and Test-Retest Reproducibility of
Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
[TBL] [Abstract][Full Text] [Related]
4. 11C-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: synthesis and evaluation in baboons.
Talbot PS; Narendran R; Butelman ER; Huang Y; Ngo K; Slifstein M; Martinez D; Laruelle M; Hwang DR
J Nucl Med; 2005 Mar; 46(3):484-94. PubMed ID: 15750163
[TBL] [Abstract][Full Text] [Related]
5. Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation.
Li S; Zheng MQ; Naganawa M; Gao H; Pracitto R; Shirali A; Lin SF; Teng JK; Ropchan J; Huang Y
Mol Pharm; 2019 Apr; 16(4):1523-1531. PubMed ID: 30726092
[TBL] [Abstract][Full Text] [Related]
6. Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics.
Li S; Zheng MQ; Naganawa M; Kim S; Gao H; Kapinos M; Labaree D; Huang Y
J Nucl Med; 2019 Jul; 60(7):1023-1030. PubMed ID: 30630942
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.
Naganawa M; Jacobsen LK; Zheng MQ; Lin SF; Banerjee A; Byon W; Weinzimmer D; Tomasi G; Nabulsi N; Grimwood S; Badura LL; Carson RE; McCarthy TJ; Huang Y
Neuroimage; 2014 Oct; 99():69-79. PubMed ID: 24844744
[TBL] [Abstract][Full Text] [Related]
8. An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of (11)C-LY2459989.
Zheng MQ; Kim SJ; Holden D; Lin SF; Need A; Rash K; Barth V; Mitch C; Navarro A; Kapinos M; Maloney K; Ropchan J; Carson RE; Huang Y
J Nucl Med; 2014 Jul; 55(7):1185-91. PubMed ID: 24854795
[TBL] [Abstract][Full Text] [Related]
9. Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging.
Placzek MS; Schroeder FA; Che T; Wey HY; Neelamegam R; Wang C; Roth BL; Hooker JM
ACS Chem Neurosci; 2019 Jan; 10(1):384-395. PubMed ID: 30212182
[TBL] [Abstract][Full Text] [Related]
10. Kappa opioid receptor binding in major depression: A pilot study.
Miller JM; Zanderigo F; Purushothaman PD; DeLorenzo C; Rubin-Falcone H; Ogden RT; Keilp J; Oquendo MA; Nabulsi N; Huang YH; Parsey RV; Carson RE; Mann JJ
Synapse; 2018 Sep; 72(9):e22042. PubMed ID: 29935119
[TBL] [Abstract][Full Text] [Related]
11. Determination of the in vivo selectivity of a new κ-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey.
Kim SJ; Zheng MQ; Nabulsi N; Labaree D; Ropchan J; Najafzadeh S; Carson RE; Huang Y; Morris ED
J Nucl Med; 2013 Sep; 54(9):1668-74. PubMed ID: 23918735
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging.
Zheng MQ; Nabulsi N; Kim SJ; Tomasi G; Lin SF; Mitch C; Quimby S; Barth V; Rash K; Masters J; Navarro A; Seest E; Morris ED; Carson RE; Huang Y
J Nucl Med; 2013 Mar; 54(3):455-63. PubMed ID: 23353688
[TBL] [Abstract][Full Text] [Related]
13. Novel
Li S; Cai Z; Zheng MQ; Holden D; Naganawa M; Lin SF; Ropchan J; Labaree D; Kapinos M; Lara-Jaime T; Navarro A; Huang Y
J Nucl Med; 2018 Jan; 59(1):140-146. PubMed ID: 28747521
[TBL] [Abstract][Full Text] [Related]
14. Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.
Placzek MS; Van de Bittner GC; Wey HY; Lukas SE; Hooker JM
Neuropsychopharmacology; 2015 Dec; 40(13):2865-72. PubMed ID: 26058662
[TBL] [Abstract][Full Text] [Related]
15. Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study.
Martinez D; Slifstein M; Matuskey D; Nabulsi N; Zheng MQ; Lin SF; Ropchan J; Urban N; Grassetti A; Chang D; Salling M; Foltin R; Carson RE; Huang Y
Neuropsychopharmacology; 2019 Sep; 44(10):1720-1727. PubMed ID: 31026862
[TBL] [Abstract][Full Text] [Related]
16. [11C]GR103545: novel one-pot radiosynthesis with high specific activity.
Nabulsi NB; Zheng MQ; Ropchan J; Labaree D; Ding YS; Blumberg L; Huang Y
Nucl Med Biol; 2011 Feb; 38(2):215-21. PubMed ID: 21315277
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
[TBL] [Abstract][Full Text] [Related]
18. [(11)C]-GR89696, a potent kappa opiate receptor radioligand; in vivo binding of the R and S enantiomers.
Ravert HT; Scheffel U; Mathews WB; Musachio JL; Dannals RF
Nucl Med Biol; 2002 Jan; 29(1):47-53. PubMed ID: 11786275
[TBL] [Abstract][Full Text] [Related]
19. Methylated analogues of methyl (R)-4-(3,4-dichlorophenylacetyl)- 3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate (GR-89,696) as highly potent kappa-receptor agonists: stereoselective synthesis, opioid-receptor affinity, receptor selectivity, and functional studies.
Soukara S; Maier CA; Predoiu U; Ehret A; Jackisch R; Wünsch B
J Med Chem; 2001 Aug; 44(17):2814-26. PubMed ID: 11495592
[TBL] [Abstract][Full Text] [Related]
20. GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
Rogers H; Birch PJ; Harrison SM; Palmer E; Manchee GR; Judd DB; Naylor A; Scopes DI; Hayes AG
Br J Pharmacol; 1992 Aug; 106(4):783-9. PubMed ID: 1327387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
